VX-522

· Vertex Pharmaceuticals Incorporated

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VX-522, covering 2026-03-25 to 2026-03-25. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1/2 Study of VX-522 in Participants With Cystic Fibrosis (CF) [Phase 1, Phase 2]